Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ocugen, Inc. - Common Stock (NQ: OCGN )

0.7231 +0.0052 (+0.72%)
Streaming Delayed Price Updated: 10:58 AM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
33 34 Next >
A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State
Though new variants mean people will continue seeking out booster shots, OCGN stock holders shouldn't expect people to want Ocugen's vaccine. 
Via InvestorPlace
Ocugen Shares Move Higher, Try To Recover A Key Technical Level
Ocugen Inc. (NASDAQ:OCGN) shares are trading higher Tuesda... 
Via Benzinga
Ocugen Stock Is Down but Not Out
Even as investors lose hope in its Covid-19 vaccine catalyst, it isn't quite 'game over' for OCGN stock. A possible volatile long-term play. 
Via InvestorPlace
Looking Into Ocugen Inc's Recent Short Interest
Ocugen Inc's (NASDAQ:OCGN) short percent of float has fallen 14.6% since last its last report. The company recently reported that it has 46.93 million shares sold short, which is... 
Via Benzinga
CANF Stock Alert: The Liver Cancer News Catapulting Can-Fite BioPharma Shares Higher Today
Can-Fite BioPharma (CANF) stock is rocketing higher on Monday thanks to new data from a Phase II clinical trial for liver cancer. 
Via InvestorPlace
OCGN Stock Alert: What Is Going on With Ocugen Today?
OCGN stock has been on a turbulent ride this morning following updates from Ocugen's partner Bharat Biotech. Here's what to know. 
Via InvestorPlace
As Covaxin Catalyst Fades, Stay Away From Ocugen Stock
It may be making progress with another candidate in its pipeline, but as it ceases to be a vaccine play, OCGN stock will head lower. 
Via InvestorPlace
OCGN Stock Moves Higher on New Vaccine Data. What to Know.
Shares of OCGN stock are getting some relief today and moving higher on positive results for its vaccine candidate. 
Via InvestorPlace
What's Going On With Ocugen Stock Today
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
The weekend break is over and that means it's time to get back to work with the biggest pre-market stock movers for Monday! 
Via InvestorPlace
25 Stocks Moving in Monday's Pre-Market Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index. Verso Corporation (NYSE:... 
Via Benzinga
Don’t Expect Digital World to Tumble From Its New Deal With Rumble
Trump Media & Technology Group announced a partnership with Rumble. Hiring the Canadian firm probably won’t be what makes DWAC stock tumble. 
Via InvestorPlace
7 Meme Stocks to Sell Before They Lose Momentum
Meme stocks run the gamut from senseless to sensible. These seven unfortunately fall in the former camp, so steer clear. 
Via InvestorPlace
Christmas Is a Time for Ocugen Shareholders to Give Thanks
This time last year, Ocugen traded below 30 cents. Up 1,683% since, owners of OCGN stock ought to be grateful for their unexpected returns. 
Via InvestorPlace
Nio Day 2022: 13 Things for Nio Stock Investors to Expect on Dec. 18
Nio (NIO) Day is quickly approaching and there are loads of rumors about electric vehicle (EV) reveals that have investors excited today. 
Via InvestorPlace
EV Stocks Outlook for 2022: Why One Analyst Sees Investor Enthusiasm Cooling Next Year
One analyst believes the outlook for electric vehicle (EV) stocks in 2022 won't offer the same support it has during the current year. 
Via InvestorPlace
Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination
Ocugen Inc (NASDAQ: OCGN) announced that immune response data following two doses of Covaxin from a third-party study were published on the preprint server, ... 
Via Benzinga
How Worrisome Is Ocugen's Latest Bad News?
Investors don't need to be too concerned about the FDA's clinical hold on a Covaxin study-- for now. 
Via The Motley Fool
Exposures COVID-19 Product Safety
How Are The Shorts Feeling About Ocugen Inc?
What happened: Ocugen Inc's (NASDAQ:OCGN) short interest has fallen 14% since the last report. The company recently reported that it has 46 million shares sold short, which is... 
Via Benzinga
RNG Stock Alert: The COO News That RingCentral Investors Hanging Up Their Shares Today
RingCentral (RNG) stock isn't doing so hot on Thursday with heavy trading after the company announced a change in leadership. 
Via InvestorPlace
Investor Fears About Covaxin Have Ocugen Shares on Sale
OCGN stock at this point is either an inexpensive Covid-19 vaccine stock or an over-priced investigational gene therapy stock — or both. 
Via InvestorPlace
Exposures COVID-19
RENN Stock Alert: Why “Facebook of China” Renren Is Plunging Today
Renren (RENN) stock is falling hard on Thursday following an update on a $300 million court case against the Facebook of China. 
Via InvestorPlace
Topics Lawsuit
Exposures Financial Legal
OCGN Stock Pops on Key FDA News. Here’s What to Know.
Ocugen is slipping today even after promising news breaks related to its gene therapy program, OCU400. Where is OCGN stock heading? 
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
2 Big Stock Bets That Are Insiders Are Buying Now
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. 
Via InvestorPlace
Ocugen Investors Are Betting On a Horse Than Can’t Win the Race
Don't go bottom-fishing with OCGN stock even if it's at an enticing support level 
Via InvestorPlace
Ocugen Looks Risky as Markets Tire Of Speculative Vaccine Plays
The window of opportunity is closing for also-ran vaccine makers, which is why OCGN has become a very volatile stock in the vaccine space. 
Via InvestorPlace
Exposures COVID-19
Ocugen Stock Very Well May Have Bottomed Out Here
I don’t know if InvestorPlace’s Larry Ramer is still short, but if he is, he’s made a few bucks with OCGN stock down in the past month. 
Via InvestorPlace
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail?
Smaller companies are working on next-generation approaches to Covid treatment. 
Via Investor's Business Daily
20 Stocks Moving in Monday's Pre-Market Session
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.